Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Summary of Activity and Information regarding Outstanding and Exercisable Options (Details)

v3.23.1
Stockholders' Equity - Summary of Activity and Information regarding Outstanding and Exercisable Options (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Equity [Abstract]    
Options Outstanding, Beginning balance 6,545,628  
Options Outstanding, Granted 672,287  
Options Outstanding, Ending balance 7,217,915 6,545,628
Options Outstanding, Options exercisable 5,676,837  
Weighted Average Exercise Price, Beginning balance $ 2.55  
Weighted Average Exercise Price, Granted 4.08  
Weighted Average Exercise Price, Ending balance 2.69 $ 2.55
Weighted Average Exercise Price, Options exercisable $ 2.29  
Weighted Average Remaining Contractual Term in Years 7 years 9 months 25 days 7 years 7 months 2 days
Weighted Average Remaining Contractual Term in Years, Options exercisable 7 years 4 months 20 days  
Aggregate Intrinsic Value $ 8,907,071  
Aggregate Intrinsic Value, Options exercisable $ 8,591,943